Publications

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

 144
GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

Tags:

Previous Article

Oncogene mutation in colorectal cancer leads to metabolic reprogramming

Next Article

GRK-biased adrenergic agonists for the treatment of type 2 diabetes and obesity

Related Posts

Deep Learning Predicts Dissimilar DNA-DNA Binding and Engineers Hyperconnected Networks

Deep Learning Predicts Dissimilar DNA-DNA Binding and E...

 54

Left ventricular myocardial molecular profile of human diabetic ischaemic cardiomyopathy

Left ventricular myocardial molecular profile of human ...

 86

Assembly of the infant gut microbiome and resistome are linked to bacterial strains in mother’s milk

Assembly of the infant gut microbiome and resistome are...

 58